5-bromo-6-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid;tert-butyl 4-[3-bromo-5-[(3,4-difluorophenyl)methyl-ethylcarbamoyl]-2-pyridinyl]piperazine-1-carboxylate;N-[(3,4-difluorophenyl)methyl]ethanamine
C48H60Br2F4N8O7 — CID 157059584
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-bromo-6-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid;tert-butyl 4-[3-bromo-5-[(3,4-difluorophenyl)methyl-ethylcarbamoyl]-2-pyridinyl]piperazine-1-carboxylate;N-[(3,4-difluorophenyl)methyl]ethanamine
5-bromo-6-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid;tert-butyl 4-[3-bromo-5-[(3,4-difluorophenyl)methyl-ethylcarbamoyl]-2-pyridinyl]piperazine-1-carboxylate;N-[(3,4-difluorophenyl)methyl]ethanamine (PubChem CID 157059584) has the molecular formula C48H60Br2F4N8O7 and a molecular weight of 1096.86 g/mol. Its IUPAC name is 5-bromo-6-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid;tert-butyl 4-[3-bromo-5-[(3,4-difluorophenyl)methyl-ethylcarbamoyl]-2-pyridinyl]piperazine-1-carboxylate;N-[(3,4-difluorophenyl)methyl]ethanamine.
Molecular Properties
| Compound Name | 5-bromo-6-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid;tert-butyl 4-[3-bromo-5-[(3,4-difluorophenyl)methyl-ethylcarbamoyl]-2-pyridinyl]piperazine-1-carboxylate;N-[(3,4-difluorophenyl)methyl]ethanamine |
|---|---|
| PubChem CID | 157059584 |
| Molecular Formula | C48H60Br2F4N8O7 |
| Molecular Weight | 1096.86 g/mol |
| Exact Mass | 1094.29 |
| IUPAC Name | 5-bromo-6-[4-[(2-methylpropan-2-yl)oxycarbonyl]piperazin-1-yl]pyridine-3-carboxylic acid;tert-butyl 4-[3-bromo-5-[(3,4-difluorophenyl)methyl-ethylcarbamoyl]-2-pyridinyl]piperazine-1-carboxylate;N-[(3,4-difluorophenyl)methyl]ethanamine |
| SMILES | CC(C)(C)OC(=O)N1CCN(c2ncc(C(=O)O)cc2Br)CC1.CCN(Cc1ccc(F)c(F)c1)C(=O)c1cnc(N2CCN(C(=O)OC(C)(C)C)CC2)c(Br)c1.CCNCc1ccc(F)c(F)c1 |
| InChI | InChI=1S/C24H29BrF2N4O3.C15H20BrN3O4.C9H11F2N/c1-5-29(15-16-6-7-19(26)20(27)12-16)22(32)17-13-18(25)21(28-14-17)30-8-10-31(11-9-30)23(33)34-24(2,3)4;1-15(2,3)23-14(22)19-6-4-18(5-7-19)12-11(16)8-10(9-17-12)13(20)21;1-2-12-6-7-3-4-8(10)9(11)5-7/h6-7,12-14H,5,8-11,15H2,1-4H3;8-9H,4-7H2,1-3H3,(H,20,21);3-5,12H,2,6H2,1H3 |
| InChIKey | ABEAYIRRGHTWPN-UHFFFAOYSA-N |
| XLogP | 9.52 |
| TPSA | 160.98 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 11 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 69 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1096.86 |
| LogP ≤ 5 | 9.52 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 11 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 157059584 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.